Loss of LGR5 through Therapy-Induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells

Combination treatment of MET-STAT3 inhibitors with irinotecan or antibody-drug conjugates substantiated synergistic effects in colorectal cancer cells and tumor organoids.
[Molecular Cancer Therapeutics]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News